ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial designIgnace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon van Gorp, Debra Richardson, Michael McCarthySee the full list of authors
16 April 2024
Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancerChristhardt Kohler, Andrea Plaikner, Kathrin Siegler, Hermann Hertel, Kati Hasenbein, Anja Petzel, Melanie Schubert, Jens-Uwe Blohmer, Gerd Böhmer, Claudia Stolte, Simone Marnitz, Nina Mallmann-Gottschalk, Peter Oppelt, Giovanni Favero, Silke WestphalenSee the full list of authors
10 April 2024
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trialTine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen
6 March 2024
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trialDomenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues BourgeoisSee the full list of authors
21 December 2023
Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumorsKoji Matsumoto, Yoshinori Sunaga, Evelyne Ecstein-Fraisse, Keiichi Fujiwara
20 November 2023
Rectal sparing in modified posterior exenteration: description of the technique in 10 stepsNavid Mokarram Dorri, Guillaume Blache, Jonathan Garnier, Gilles Houvenaeghel, Houssein El Hajj, Eric Lambaudie
21 March 2024
Analysis of risk factors for post-operative recurrence or progression of intravenous leiomyomatosisGuorui Zhang, Xin Yu, Jinghe Lang, Bao Liu, Dachun Zhao
19 March 2024
Staging by imaging in gynecologic cancer and the role of ultrasound: an update of European joint consensus statementsDaniela Fischerova, Carolina Smet, Umberto Scovazzi, Diana Natacha Sousa, Kristina Hundarova, Ingfrid Salvesen Haldorsen
4 March 2024
Cost-effectiveness of olaparib plus bevacizumab versus bevacizumab monotherapy in the maintenance of patients with homologous recombination deficiency-positive advanced ovarian cancer after response to first-line platinum-based chemotherapySergio Cedillo, Carla Garí, Susana Aceituno, Luis Manso, Ana Cristina Cercos Lleti, Pedro Ventayol Bosch, Antonio Casado, Alejandro Perez Fidalgo
2 December 2023
The Womb Cancer Awareness Measure (WCAM): development of an instrument to assess public awareness of endometrial cancerOlivia Jones, Hannah Young, Helen Clarke, Emma J Crosbie, Vanitha N Sivalingam
6 December 2023
